Detalles de la búsqueda
1.
Pitavastatin to Prevent Cardiovascular Disease in HIV Infection.
N Engl J Med;
389(8): 687-699, 2023 Aug 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37486775
2.
Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE).
Clin Infect Dis;
76(11): 2010-2013, 2023 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36825498
3.
Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV).
Clin Infect Dis;
76(3): e613-e621, 2023 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35975297
4.
Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United States.
Clin Infect Dis;
76(2): 323-334, 2023 01 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36101518
5.
Pericoronary Adipose Tissue Density, Inflammation, and Subclinical Coronary Artery Disease Among People With HIV in the REPRIEVE Cohort.
Clin Infect Dis;
77(12): 1676-1686, 2023 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37439633
6.
Regional Differences in Added Sweetener Knowledge, Consumption and Body Mass Index in People with HIV in the United States.
AIDS Behav;
27(3): 816-822, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36094637
7.
COVID-19 Vaccination Rates in a Global HIV Cohort.
J Infect Dis;
225(4): 603-607, 2022 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34794178
8.
Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic Substudy.
J Infect Dis;
226(10): 1809-1822, 2022 11 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35535576
9.
Strengths and Challenges of Various Models of Geriatric Consultation for Older Adults Living With Human Immunodeficiency Virus.
Clin Infect Dis;
74(6): 1101-1106, 2022 03 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34358303
10.
Geographical Differences in the Self-Reported Functional Impairment of People With Human Immunodeficiency Virus (HIV) and Associations With Cardiometabolic Risk.
Clin Infect Dis;
75(7): 1154-1163, 2022 09 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35165682
11.
Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy.
Clin Infect Dis;
75(8): 1324-1333, 2022 10 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35235653
12.
Role of renin-angiotensin-aldosterone system activation and other metabolic variables in relation to arterial inflammation in HIV.
Clin Endocrinol (Oxf);
97(5): 581-587, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35614846
13.
The Association of Distinct Social Determinants of Health with Added Sweetener Knowledge and Consumption in a U.S. Sample of People Living with HIV.
AIDS Behav;
26(5): 1552-1561, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-34731406
14.
Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE Trial.
Clin Infect Dis;
73(11): 2009-2022, 2021 12 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34134131
15.
Differential Plasma Protein Regulation and Statin Effects in Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected Patients Utilizing a Proteomics Approach.
J Infect Dis;
222(6): 929-939, 2020 08 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-32310273
16.
Physical Function Impairment and Frailty in Middle-Aged People Living With Human Immunodeficiency Virus in the REPRIEVE Trial Ancillary Study PREPARE.
J Infect Dis;
222(Suppl 1): S52-S62, 2020 07 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32645163
17.
An Evaluation of Baseline Kidney Function in the REPRIEVE Trial of Pitavastatin in Human Immunodeficiency Virus.
J Infect Dis;
222(Suppl 1): S41-S51, 2020 07 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32645164
18.
Correlates and Timing of Reproductive Aging Transitions in a Global Cohort of Midlife Women With Human Immunodeficiency Virus: Insights From the REPRIEVE Trial.
J Infect Dis;
222(Suppl 1): S20-S30, 2020 07 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32645159
19.
Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum.
J Infect Dis;
222(Suppl 1): S31-S40, 2020 07 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32645160
20.
Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial.
J Infect Dis;
222(Suppl 1): S8-S19, 2020 07 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32645162